Citius Oncology, Inc. CTOR December2025Sale Of Common Stock And Prefunded Warrants Net Of Costs
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept ctor:December2025SaleOfCommonStockAndPrefundedWarrantsNetOfCosts.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s december2025sale of common stock and prefunded warrants net of costs.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s december2025sale of common stock and prefunded warrants net of costs?
- Citius Oncology, Inc. (CTOR) reported december2025sale of common stock and prefunded warrants net of costs of $2.87M in Q4 2025.